Edwards Lifesciences Statistics Share Statistics Edwards Lifesciences has 587.1M
shares outstanding. The number of shares has increased by -2.62%
in one year.
Shares Outstanding 587.1M Shares Change (YoY) -2.62% Shares Change (QoQ) 0.14% Owned by Institutions (%) 84.84% Shares Floating 575.19M Failed to Deliver (FTD) Shares 180 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 6.91M, so 1.18% of the outstanding
shares have been sold short.
Short Interest 6.91M Short % of Shares Out 1.18% Short % of Float 1.34% Short Ratio (days to cover) 2.13
Valuation Ratios The PE ratio is 10.6 and the forward
PE ratio is 28.09.
Edwards Lifesciences's PEG ratio is
0.05.
PE Ratio 10.6 Forward PE 28.09 PS Ratio 8.13 Forward PS 7 PB Ratio 4.43 P/FCF Ratio 152.63 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Edwards Lifesciences has an Enterprise Value (EV) of 41.9B.
EV / Sales 7.7 EV / EBITDA 24.32 EV / EBIT 77.27 EV / FCF 144.54
Financial Position The company has a current ratio of 4.18,
with a Debt / Equity ratio of 0.07.
Current Ratio 4.18 Quick Ratio 3.45 Debt / Equity 0.07 Debt / EBITDA 0.41 Debt / FCF 2.41 Interest Coverage 72.94
Financial Efficiency Return on Equity is 41.75% and Return on Invested Capital is 11.23%.
Return on Equity 41.75% Return on Assets 31.98% Return on Invested Capital 11.23% Revenue Per Employee $344.27K Profits Per Employee $264.22K Employee Count 15,800 Asset Turnover 0.42 Inventory Turnover 1.06
Taxes Income Tax 152.1M Effective Tax Rate 9.82%
Stock Price Statistics The stock price has increased by 19.33% in the
last 52 weeks. The beta is 1.08, so Edwards Lifesciences's
price volatility has been higher than the market average.
Beta 1.08 52-Week Price Change 19.33% 50-Day Moving Average 77.24 200-Day Moving Average 73.17 Relative Strength Index (RSI) 51.3 Average Volume (20 Days) 4,417,190
Income Statement In the last 12 months, Edwards Lifesciences had revenue of 5.44B
and earned 4.17B
in profits. Earnings per share was 6.98.
Revenue 5.44B Gross Profit 4.29B Operating Income 1.44B Net Income 4.17B EBITDA 1.72B EBIT 1.57B Earnings Per Share (EPS) 6.98
Full Income Statement Balance Sheet The company has 3.05B in cash and 700M in
debt, giving a net cash position of 2.35B.
Cash & Cash Equivalents 3.05B Total Debt 700M Net Cash 2.35B Retained Earnings 13.17B Total Assets 13.49B Working Capital 5.17B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 542.3M
and capital expenditures -252.4M, giving a free cash flow of 289.9M.
Operating Cash Flow 542.3M Capital Expenditures -252.4M Free Cash Flow 289.9M FCF Per Share 0.49
Full Cash Flow Statement Margins Gross margin is 78.8%, with operating and profit margins of 26.55% and 76.75%.
Gross Margin 78.8% Operating Margin 26.55% Pretax Margin 28.46% Profit Margin 76.75% EBITDA Margin 31.68% EBIT Margin 26.55% FCF Margin 5.33%
Dividends & Yields EW does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 9.43% FCF Yield 0.66%
Dividend Details Analyst Forecast The average price target for EW is $89,
which is 13.8% higher than the current price. The consensus rating is "Buy".
Price Target $89 Price Target Difference 13.8% Analyst Consensus Buy Analyst Count 20
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $174.5 Lynch Upside 123.12% Graham Number 51.27 Graham Upside -34.45%
Stock Splits The last stock split was on Jun 1, 2020. It was a
forward
split with a ratio of 3:1.
Last Split Date Jun 1, 2020 Split Type forward Split Ratio 3:1
Scores Altman Z-Score 12.2 Piotroski F-Score 5
